Your browser doesn't support javascript.
loading
Occupational Benzene Exposure and Lung Cancer Risk: A Pooled Analysis of 14 Case-Control Studies.
Wan, Wenxin; Peters, Susan; Portengen, Lützen; Olsson, Ann; Schüz, Joachim; Ahrens, Wolfgang; Schejbalova, Miriam; Boffetta, Paolo; Behrens, Thomas; Brüning, Thomas; Kendzia, Benjamin; Consonni, Dario; Demers, Paul A; Fabiánová, Eleonóra; Fernández-Tardón, Guillermo; Field, John K; Forastiere, Francesco; Foretova, Lenka; Guénel, Pascal; Gustavsson, Per; Jöckel, Karl-Heinz; Karrasch, Stefan; Landi, Maria Teresa; Lissowska, Jolanta; Barul, Christine; Mates, Dana; McLaughlin, John R; Merletti, Franco; Migliore, Enrica; Richiardi, Lorenzo; Pándics, Tamás; Pohlabeln, Hermann; Siemiatycki, Jack; Swiatkowska, Beata; Wichmann, Heinz-Erich; Zaridze, David; Ge, Calvin; Straif, Kurt; Kromhout, Hans; Vermeulen, Roel.
Afiliação
  • Wan W; Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
  • Peters S; Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
  • Portengen L; Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
  • Olsson A; International Agency for Research on Cancer/World Health Organization, Lyon, France.
  • Schüz J; International Agency for Research on Cancer/World Health Organization, Lyon, France.
  • Ahrens W; Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany.
  • Schejbalova M; Faculty of Mathematics and Computer Science, Institute of Statistics, University of Bremen, Bremen, Germany.
  • Boffetta P; Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University, Prague, Czechia.
  • Behrens T; Stony Brook Cancer Center, Stony Brook University, Stony Brook, New York.
  • Brüning T; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Kendzia B; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University, Bochum, Germany.
  • Consonni D; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University, Bochum, Germany.
  • Demers PA; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University, Bochum, Germany.
  • Fabiánová E; Epidemiology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Fernández-Tardón G; Occupational Cancer Research Centre, Ontario Health, Toronto, Ontario, Canada.
  • Field JK; Regional Authority of Public Health, Banská Bystrica, Slovakia.
  • Forastiere F; Faculty of Health, Catholic University, Ruzomberok, Slovakia.
  • Foretova L; Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain.
  • Guénel P; Health Research Institute of Asturias, University Institute of Oncology of Asturias - Cajastur Social Program, University of Oviedo, Oviedo, Spain.
  • Gustavsson P; Roy Castle Lung Cancer Research Programme, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.
  • Jöckel KH; Department of Epidemiology, Azienda Sanitaria Locale Roma E, Rome, Italy.
  • Karrasch S; Masaryk Memorial Cancer Institute, Brno, Czechia.
  • Landi MT; Center for Research in Epidemiology and Population Health, Team Exposome and Heredity, U1018 Institut national de la santé et de la recherche médicale, University of Paris-Saclay, Villejuif, France.
  • Lissowska J; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Barul C; Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany.
  • Mates D; Institute and Clinic for Occupational, Social and Environmental Medicine, University Hospital, and.
  • McLaughlin JR; Comprehensive Pneumology Center Munich, Member of the German Center for Lung Research, Munich, Germany.
  • Merletti F; Institute of Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
  • Migliore E; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
  • Richiardi L; Epidemiology Unit, Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Pándics T; Université Rennes, Institut national de la santé et de la recherche médicale, École des hautes études en santé publique, Institut de recherche en santé, environnement et travail, UMR_S 1085, Pointe-à-Pitre, France.
  • Pohlabeln H; National Institute of Public Health, Bucharest, Romania.
  • Siemiatycki J; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Swiatkowska B; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Wichmann HE; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Zaridze D; Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Ge C; National Public Health Center, Budapest, Hungary.
  • Straif K; Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany.
  • Kromhout H; Department of Social and Preventive Medicine, University of Montreal, Montreal, Quebec, Canada.
  • Vermeulen R; Department of Environmental Epidemiology, The Nofer Institute of Occupational Medicine, Lodz, Poland.
Am J Respir Crit Care Med ; 209(2): 185-196, 2024 Jan 15.
Article em En | MEDLINE | ID: mdl-37812782
Rationale: Benzene has been classified as carcinogenic to humans, but there is limited evidence linking benzene exposure to lung cancer. Objectives: We aimed to examine the relationship between occupational benzene exposure and lung cancer. Methods: Subjects from 14 case-control studies across Europe and Canada were pooled. We used a quantitative job-exposure matrix to estimate benzene exposure. Logistic regression models assessed lung cancer risk across different exposure indices. We adjusted for smoking and five main occupational lung carcinogens and stratified analyses by smoking status and lung cancer subtypes. Measurements and Main Results: Analyses included 28,048 subjects (12,329 cases, 15,719 control subjects). Lung cancer odds ratios ranged from 1.12 (95% confidence interval, 1.03-1.22) to 1.32 (95% confidence interval, 1.18-1.48) (Ptrend = 0.002) for groups with the lowest and highest cumulative occupational exposures, respectively, compared with unexposed subjects. We observed an increasing trend of lung cancer with longer duration of exposure (Ptrend < 0.001) and a decreasing trend with longer time since last exposure (Ptrend = 0.02). These effects were seen for all lung cancer subtypes, regardless of smoking status, and were not influenced by specific occupational groups, exposures, or studies. Conclusions: We found consistent and robust associations between different dimensions of occupational benzene exposure and lung cancer after adjusting for smoking and main occupational lung carcinogens. These associations were observed across different subgroups, including nonsmokers. Our findings support the hypothesis that occupational benzene exposure increases the risk of developing lung cancer. Consequently, there is a need to revisit published epidemiological and molecular data on the pulmonary carcinogenicity of benzene.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Exposição Ocupacional / Neoplasias Pulmonares / Doenças Profissionais Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Am J Respir Crit Care Med Assunto da revista: TERAPIA INTENSIVA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Exposição Ocupacional / Neoplasias Pulmonares / Doenças Profissionais Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Am J Respir Crit Care Med Assunto da revista: TERAPIA INTENSIVA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Holanda